NASDAQ:RVMD | Free Cash Flow | Revolution Medicines, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$354.17M$1.54M-$355.7M
2025-12-31-$274.24M$1.93M-$276.16M
2025-03-31-$194.44M$3.27M-$197.7M
2024-12-31-$138.29M$1.22M-$139.51M
2024-03-31-$160.56M$3.17M-$163.73M
2023-12-31-$120.56M$2.32M-$122.88M
2023-03-31-$62.39M$1.76M-$64.15M
2022-12-31-$61.79M$2.88M-$64.66M
2022-03-31-$55.16M$1.89M-$57.05M
2021-12-31-$39.27M$1.18M-$40.45M
2021-03-31-$37.25M$3.58M-$40.83M
2020-12-31-$25.03M$1.17M-$26.2M
2020-03-31-$28.02M$603,000.00-$28.62M
2019-12-31-$11.65M$510,000.00-$12.16M
2019-03-31-$12.61M$341,000.00-$12.95M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$897.74M$15.99M-$913.73M
2024-12-31-$557.44M$10.31M-$567.74M
2023-12-31-$350.57M$7.73M-$358.3M
2022-12-31-$224.4M$10.82M-$235.22M
2021-12-31-$147.18M$6.53M-$153.71M
2020-12-31-$100.06M$2.93M-$103M
2019-12-31-$49.62M$2.59M-$52.21M
2018-12-31$1.21M$1.5M-$286,000.00